Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 24200746)

Published in J Control Release on November 05, 2013

Authors

Fabio R Formiga1, Beatriz Pelacho2, Elisa Garbayo1, Izaskun Imbuluzqueta1, Paula Díaz-Herráez1, Gloria Abizanda2, Juan J Gavira2, Teresa Simón-Yarza1, Edurne Albiasu2, Esther Tamayo1, Felipe Prósper3, Maria J Blanco-Prieto4

Author Affiliations

1: Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, Pamplona, Spain.
2: Hematology, Cardiology and Cell Therapy, Clínica Universidad de Navarra, Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain.
3: Hematology, Cardiology and Cell Therapy, Clínica Universidad de Navarra, Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain. Electronic address: fprosper@unav.es.
4: Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, Pamplona, Spain. Electronic address: mjblanco@unav.es.

Articles citing this

Recombinant neuregulin 1 does not activate cardiomyocyte DNA synthesis in normal or infarcted adult mice. PLoS One (2014) 1.06

The roles of neuregulin-1 in cardiac development, homeostasis, and disease. Biomark Insights (2015) 0.84

Micro- and Nanoparticles for Treating Cardiovascular Disease. Biomater Sci (2015) 0.81

Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. Biomaterials (2015) 0.80

Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. Cell Death Dis (2015) 0.79

Fibrous scaffolds for building hearts and heart parts. Adv Drug Deliv Rev (2015) 0.78

Neuregulin-1 Administration Protocols Sufficient for Stimulating Cardiac Regeneration in Young Mice Do Not Induce Somatic, Organ, or Neoplastic Growth. PLoS One (2016) 0.78

Recent developments in protein and peptide parenteral delivery approaches. Ther Deliv (2014) 0.78

Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration. World J Cardiol (2016) 0.78

Neuregulin-1β induces mature ventricular cardiac differentiation from induced pluripotent stem cells contributing to cardiac tissue repair. Stem Cells Dev (2014) 0.77

Engineered Biomaterials to Enhance Stem Cell-Based Cardiac Tissue Engineering and Therapy. Macromol Biosci (2016) 0.76

A specified therapeutic window for neuregulin-1 to regenerate neonatal heart muscle. Ann Transl Med (2015) 0.76

Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide? Stem Cells Int (2016) 0.76

Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion. Sci Rep (2016) 0.75

IgG-Containing Isoforms of Neuregulin-1 Are Dispensable for Cardiac Trabeculation in Zebrafish. PLoS One (2016) 0.75

New Trends in Heart Regeneration: A Review. J Stem Cells Regen Med (2016) 0.75

How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction. Front Bioeng Biotechnol (2016) 0.75

Cardiac Regeneration using Growth Factors: Advances and Challenges. Arq Bras Cardiol (2016) 0.75